Biotech Startups

Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors. It combines targeted therapy precision with immune-based approaches to create more durable treatment options for patients with difficult-to-treat cancers.

1 investor

HapticHeart Solutions builds a device-agnostic system that converts biophysical and physiological signals from cardiac catheterization, electrophysiology, and robotic interventions into haptic feedback delivered to operators through a wearable interface and handle. It targets clinical operators performing catheter-based structural heart and cardiac electrophysiology procedures, aiming to simulate direct tactile sensing such as intracardiac pressure and catheter-tissue contact force.

1 investor

Harbinger Health develops early cancer detection technology through its Harbinger HX platform, which embeds developmental biology into biomarker discovery, assay design, and model training to detect faint biological signals of early cancer in real-world samples. The company builds tools for oncology and cancer management.

1 investor

Harmony Pharma Group provides CMC (chemistry, manufacturing, and controls) consulting for small molecule and antibody drug conjugate development, offering technical, regulatory, and quality strategy from early bench work through clinical stages to commercialization. It also supports implementation of these plans at CDMOs on behalf of pharmaceutical clients.

1 investor

Harpe Bioherbicide Solutions develops natural, bio-based weed control products for agriculture and, through a partnership with SBM Life Science, the home and garden consumer market. The company works on next-generation bioherbicide solutions.

1 investor

Genesis Molecular uses deep learning and molecular simulation to accelerate drug discovery and development. The platform helps identify and optimize drug candidates for challenging diseases.

1 investor

Harton Therapeutics offers a GMP-ready platform for advanced 3D cell manufacturing, using a perfusion-based single-use cartridge system with automated process control to produce human cells at scale. It serves researchers, biotech and pharma teams, and manufacturing partners working on immune cell therapies, HSPCs, engineered cells, and stem-derived cells and tissues.

1 investor

Harvard Bioscience manufactures and supplies life science research tools and laboratory equipment for academic institutions and pharmaceutical companies. The company serves the research and development market with advanced instrumentation and solutions.

1 investor

Harvest Moon is developing animal-free dairy products that aim to match conventional dairy while being lactose- and cholesterol-free, lower in sugar, and higher in nutrition. Its production process uses less land, water, and energy and produces fewer GHG emissions than conventional dairy.

1 investor

HiRO is a full-service global contract research organization (CRO) that manages clinical trials for biotech companies, integrating regulatory strategy, clinical data science, clinical operations, medical monitoring, and quality into a single execution model. It operates across regions including North America and APAC and serves biotech sponsors developing drugs and therapies across therapeutic areas such as oncology and rare diseases.

1 investor

Hausen manufactures molecular diagnostic tests for detecting HPV, respiratory pathogens, and leukemia fusion genes using real-time PCR technology for clinical and laboratory use.

1 investor

Hawthorne Health operates a network of 12 community-based clinical research sites and offers in-home visits to conduct clinical trials, aiming to improve patient enrollment, retention, and protocol-compliant data. It serves study sponsors across therapeutic areas including cardiovascular, dermatology, immunology, neurology, and rare disease.</parameter> <parameter name="founders">[]

1 investor

HaystackAnalytics develops clinical genomics products for diagnostic labs and hospitals to deliver accurate and personalized diagnostics. The company specializes in genomics-based infectious disease diagnostics, particularly for tuberculosis detection in India.

1 investor

Kaipu (Kepu) operates a network of medical laboratories and inspection centers across China and Hong Kong, providing clinical diagnostic testing services, including infectious disease and COVID-19 testing. The company runs facilities in numerous cities and supports government public health and epidemic response efforts.

1 investor

HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics as first-in-class immunotherapies for autoimmune diseases, cancer, and senescence-associated dysplasia. It uses proprietary drug discovery platforms to create multi-specific cytokines, targeted immune checkpoint inhibitors, and immune-cell engagers, with lead candidates in commercial and clinical stages.

1 investor

Headlands Research operates a multinational clinical trial site network that recruits and retains diverse participant populations for medical research studies. The organization supports pharmaceutical sponsors and research sites in advancing innovative therapies through operational excellence and high-quality data collection across multiple therapeutic areas.

1 investor

Healios (Indivi) offers a neuroscience measurement platform that turns smartphones into precision instruments for frequent, at-home patient assessments. It is aimed at pharmaceutical and clinical research teams running early-phase neuroscience trials, helping them design smaller, well-powered studies.

1 investor

Health Food Symmetry manufactures and supplies PhytoBiome, a patented whole-plant prebiotic ingredient derived from sugarcane, serving the global gut health, dietary supplements, functional foods, and animal health sectors. The company operates a GMP-certified Australian facility and sells through multiple revenue streams including B2B ingredient supply, consumer retail, and white-label partnerships.

1 investor

Health in Code is a genetic diagnostics laboratory that performs full genetic studies, variant interpretation, and clinical-genetic reporting, and develops and manufactures disease diagnostic kits for specialized labs. It serves healthcare professionals and hospitals managing patients with hereditary genetic diseases, with clients in over 30 countries.

1 investor

HealthOutlook applies life sciences and machine learning methods to predict health outcomes.

1 investor

Heart Genomics is a biotechnology company developing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Its tests analyze a patient's heart tissue or blood sample to provide personalized information that helps patients and physicians make treatment decisions within the molecular diagnostics market.

1 investor

Hedgehog Mushrooms uses artificial intelligence and proprietary bioreactors to optimize fungal cultivation conditions, producing food, biochemicals, animal feed, enzymes, and other products from fungi-based fermentation. The company serves food and agricultural industries seeking sustainable, fungal-derived ingredients and materials.

1 investor

Helix is a population genomics company that provides an end-to-end platform to integrate genomic data into clinical care, research, and therapeutic development. It partners with health systems, providers, payers, life sciences organizations, and patients to enable genetic screening and personalized healthcare at scale.

1 investor

HelixBind develops a diagnostic platform for bloodstream infections that delivers microbiology results in about 4 hours to help clinicians identify invasive infections and choose antimicrobial treatments. Its technology targets sepsis diagnosis and aims to support faster, more accurate pathogen identification for hospitals and physicians.

1 investor